Trials that use: MMRM (mixed model for repeated measures)
New to this method? Read the tutorial →
3,925 results
- Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OLOLIndependent statistical analysis of Our Lifestyles Our Lives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02965729).
- Olopatadine Eye Drops and Allergy Skin Testing: Complete Statistical AnalysisIndependent statistical analysis of Olopatadine Eye Drops and Allergy Skin Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00775658).
- Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy: Complete Statistical AnalysisIndependent statistical analysis of Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00511810).
- Omentectomy and Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Omentectomy and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00923260).
- OMS302-ILR-003Independent statistical analysis of Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Once-Daily Asenapine for Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Once-Daily Asenapine for Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01549041).
- Oncolo-GISTIndependent statistical analysis of Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ondansetron and the QT Interval In Adult Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Ondansetron and the QT Interval In Adult Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01759420).
- One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study: Complete Statistical AnalysisIndependent statistical analysis of One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580788).
- One-Day Acceptance and Commitment Training Intervention in Primary Care Patients: Complete Statistical AnalysisIndependent statistical analysis of One-Day Acceptance and Commitment Training Intervention in Primary Care Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01879800).
- One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology: Complete Statistical AnalysisIndependent statistical analysis of One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Online Caregiver Psychoeducation and Support for Alzheimer’s: Complete Statistical AnalysisIndependent statistical analysis of Online Caregiver Psychoeducation and Support for Alzheimer's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00416078).
- Online MBCT Program for University Students: Complete Statistical AnalysisIndependent statistical analysis of Online MBCT Program for University Students: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05804877).
- Online Survey in Studying Smoking Attitudes and Behaviors Among Current Smokers: Complete Statistical AnalysisIndependent statistical analysis of Online Survey in Studying Smoking Attitudes and Behaviors Among Current Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan: Complete Statistical AnalysisIndependent statistical analysis of ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ONPEDIndependent statistical analysis of Oral Naltrexone In Pediatric Eating Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05073679).
- onset 9Independent statistical analysis of Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes: primary endpoint results, effect estimate with confidence…
- onset® 1Complete statistical analysis of the onset® 1 phase 3 trial of faster-acting insulin aspart compared with insulin aspart in adults with type 1 diabetes, including the randomized design, HbA1c endpoint, MMRM methodology,…
- Open Label Safety/Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) in Patients With Cervical Dystonia: Complete Statistical AnalysisIndependent statistical analysis of Open Label Safety/Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) in Patients With Cervical Dystonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects: Complete Statistical AnalysisIndependent statistical analysis of Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.: Complete Statistical AnalysisIndependent statistical analysis of Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.: Complete Statistical AnalysisIndependent statistical analysis of Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.: primary endpoint results, effect…
- Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size…
- Open-Labeled PK-PD Studies of Metoprolol ER: Complete Statistical AnalysisIndependent statistical analysis of Open-Labeled PK-PD Studies of Metoprolol ER: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02417246).
- OPESIIndependent statistical analysis of Orthodontic Patient Experience of Intraoral Scans Versus Alginate Impressions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05194956).
- Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03876743).
- OPSISIndependent statistical analysis of Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia: primary endpoint results, effect estimate with confidence interval,…
- Opt-INIndependent statistical analysis of Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01814072).
- OpT2miseIndependent statistical analysis of OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures: Complete Statistical AnalysisIndependent statistical analysis of Optiflow THRIVE for Delivery of Oxygen to Patients During Total Intravenous Anesthesia While Undergoing Radiology Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block: Complete Statistical AnalysisIndependent statistical analysis of Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block: primary endpoint results, effect estimate with confidence interval,…
- Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT: Complete Statistical AnalysisIndependent statistical analysis of Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT: primary endpoint results, effect estimate with confidence interval, sample-size…
- Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease: Complete Statistical AnalysisIndependent statistical analysis of Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Optimizing Care for Patients With Dementia: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Care for Patients With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03442322).
- Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Optimizing Residential Treatment Gains for Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Residential Treatment Gains for Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05764369).
- Optimizing Risk Messages for Waterpipe Tobacco Cessation in Young Adults: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Risk Messages for Waterpipe Tobacco Cessation in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03595280).
- Optimizing Self-management COPD Treatment Through the American Lung Association Helpline: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Self-management COPD Treatment Through the American Lung Association Helpline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05106257).
- Optimizing the Ocular Surface Prior to Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Optimizing the Ocular Surface Prior to Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02766907).
- Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion: Complete Statistical AnalysisIndependent statistical analysis of Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oral Contraceptives in the Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Oral Contraceptives in the Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00205504).
- Oral Health Literacy Tailored Communication: Complete Statistical AnalysisIndependent statistical analysis of Oral Health Literacy Tailored Communication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01118143).
- Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD): Complete Statistical AnalysisIndependent statistical analysis of Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03028350).
- Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia: Complete Statistical AnalysisIndependent statistical analysis of Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04409041).
- Oral Nifedipine Versus Oral Labetalol: Complete Statistical AnalysisIndependent statistical analysis of Oral Nifedipine Versus Oral Labetalol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02168309).
- Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495374).